老虎證券

美股詳情
本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Enlivex Therapeutics Ltd.

1.01
+0.04004.12%
成交量：5.07萬
成交額：5.12萬
市值：2,388.75萬
市盈率：-1.38
高：1.02
開：1.01
低：1.00
收：0.9700
資料載入中...
總覽公司新聞公告
2024/11/14

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/04/30

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/04/10

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/05/03

SEC問詢函

CORRESP [Cover] - Correspondence
2022/04/29

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/06/04

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2021/04/30

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/02/10

[補充]招股説明書

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2021/02/09

[補充]招股説明書

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2020/08/14

財報披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/05/18

財報披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/04/30

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/04/13

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/18

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/05

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/26

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/24

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/14

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/01/31

SEC問詢函

CORRESP [Cover] - Correspondence
2020/01/31

[修訂]年度報告

[Amend] Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
更多